Ursodeoxycholic Acid (Highly Pure)
Catalog Number: B2010640 (1 g)
Ursodeoxycholic Acid (Highly Pure) is a highly pure bile acid commonly found in bears conjugated to taurine. This product has been used as molecular tool in the study of the metabolism of cholesterol. It has also been used in a wide array of other biochemical and immunological applications. Custom bulk amounts of this product are available upon request.
Live enquiry about this product via Text/SMS: 1-858-900-3210.
Product Description
Ursodeoxycholic Acid (Highly Pure)
Catalog number: B2010640
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 g
Molecular Weight or Concentration: 392.57 g/mol
Supplied as: Powder
Applications: molecular tool in the study of the metabolism of cholesterol
Storage: RT
Keywords: 5β-Cholan-24-oic acid-3α,7β-diol, 3α,7β-Dihydroxy-5β-cholan-24-oic acid, 7β-Hydroxylithocholic acid, UDCS
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Goossens JF, Bailly C. Ursodeoxycholic acid and cancer: From chemoprevention
to chemotherapy. Pharmacol Ther. 2019 Nov;203:107396.
2: Paumgartner G, Beuers U. Ursodeoxycholic_acid in cholestatic liver disease:
mechanisms of action and therapeutic use revisited. Hepatology. 2002
Sep;36(3):525-31.
3: Paumgartner G, Beuers U. Mechanisms of action and therapeutic efficacy of
ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis. 2004
Feb;8(1):67-81, vi.
4: Levy C, Sultan S. Is Ursodeoxycholic_Acid Really a Posttransplant Panacea?
Liver Transpl. 2021 Jun;27(6):791-793.
5: Keely SJ, Steer CJ, Lajczak-McGinley NK. Ursodeoxycholic_acid: a promising
therapeutic target for inflammatory bowel diseases? Am J Physiol Gastrointest
Liver Physiol. 2019 Dec 1;317(6):G872-G881.
6: Guarino MP, Cocca S, Altomare A, Emerenziani S, Cicala M. Ursodeoxycholic
acid therapy in gallbladder disease, a story not yet completed. World J
Gastroenterol. 2013 Aug 21;19(31):5029-34.
7: Gluud C, Christensen E. Ursodeoxycholic_acid for primary biliary cirrhosis.
Cochrane Database Syst Rev. 2002;(1):CD000551.
8: Kowdley KV. Ursodeoxycholic_acid therapy in hepatobiliary disease. Am J Med.
2000 Apr 15;108(6):481-6.
9: Drapkina OM, Bueverova EL. [Ursodeoxycholic acid: A therapeutic niche in an
internist’s practice]. Ter Arkh. 2015;87(4):84-90.
10: Wang J, Gu XZ, He LM, Li CC, Qiu WW. Synthesis of ursodeoxycholic acid from
plant-source (20S)-21-hydroxy-20-methylpregn-4-en-3-one. Steroids. 2020
May;157:108600.
Products Related to Ursodeoxycholic Acid (Highly Pure): Chemicals
Additional Information
| Weight | 0.8 oz |
|---|---|
| Dimensions | 2 × 0.9 × 0.9 in |